ProShares Pet Care ETF (PAWZ)
| Assets | $33.13M |
| Expense Ratio | 0.50% |
| PE Ratio | 22.84 |
| Forward PE | 17.52 |
| Shares Out | 650,001 |
| Dividend | $0.36 (0.72%) |
| Ex-Dividend Date | Sep 23, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 16.51% |
| Volume | 1,058 |
| Open | 50.80 |
| Previous Close | 50.86 |
| Day's Range | 50.61 - 50.80 |
| 52-Week Low | 45.96 |
| 52-Week High | 57.44 |
| Beta | 1.05 |
| Holdings | 28 |
| Inception Date | Nov 5, 2018 |
About PAWZ
Fund Home PageThe ProShares Pet Care ETF (PAWZ) is an exchange-traded fund that is based on the FactSet Pet Care index. The fund tracks a tier-weighted index of global equities related to pet ownership. PAWZ was launched on Nov 5, 2018 and is issued by ProShares.
Top 10 Holdings
70.78% of assets| Name | Symbol | Weight |
|---|---|---|
| IDEXX Laboratories, Inc. | IDXX | 10.55% |
| Zoetis Inc. | ZTS | 10.34% |
| Freshpet, Inc. | FRPT | 9.93% |
| Chewy, Inc. | CHWY | 9.75% |
| Virbac SA | VIRP | 7.46% |
| Trupanion, Inc. | TRUP | 4.84% |
| Pet Valu Holdings Ltd. | PET | 4.59% |
| Nestlé S.A. | NESN | 4.50% |
| Pets at Home Group Plc | PETS | 4.48% |
| Merck & Co., Inc. | MRK | 4.34% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 23, 2026 | $0.05639 | Sep 29, 2026 |
| Jun 24, 2026 | $0.16771 | Jun 30, 2026 |
| Mar 25, 2026 | $0.04537 | Mar 31, 2026 |
| Dec 24, 2025 | $0.09276 | Dec 31, 2025 |
| Sep 24, 2025 | $0.0416 | Sep 30, 2025 |
| Jun 25, 2025 | $0.23556 | Jul 1, 2025 |
Performance
PAWZ had a total return of -8.65% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.61%.
News
How pet medicine stocks could cushion your healthcare investments from Trump changes
Moderna shares are seeing a boost on Monday after the US Food and Drug Administration (FDA) gave the pharmaceutical giant limited approval for its lower-dose COVID-19 vaccine. Morgan Stanley Investmen...
Analysis: Pawz and UFOs: Thematic ETFs boom, drawing punters and concern
From cat food to cannabis, it's boom time for quirky ETFs offering the chance to punt on niche themes in fast-growth sectors, but their huge gains are unnerving some who see them as another price-infl...
Buy, hold or sell Procter & Gamble into earnings? and more #AskHalftime
The "Halftime Report" traders answer viewer questions in #AskHalftime.
Final Trades: Healthcare, Biotech & more
The "Halftime Report" traders give their top picks to watch for the second half
Pet Care Stocks in Play During the Pandemic
Chewy and other pet care plays could offer opportune profits during America's shutdown.
3 Charts That Suggest It's Time to Buy Pet Stocks
In 2019, U.S. pet owners are expected to spend more than $75 billion dollars on their animals.